At what enterprise value was SEV Laser acquired in 2023?

During the acquisition of SEV Laser by Levine Leichtman Capital Partners in 2023, the transaction's Enterprise Value is estimated to be in the range of 300M - 700M USD.

What was the EV/EBITDA of SEV Laser when it was acquired by Levine Leichtman Capital Partners?

The estimated EV/EBITDA multiple for SEV Laser is in the range of 15x - 25x.

When was SEV Laser acquired by Levine Leichtman Capital Partners?

SEV Laser was acquired by Levine Leichtman Capital Partners in 2023.

What was the revenue of SEV Laser at the time of the deal?

The revenue of SEV Laser at the time of the deal is estimated to be in the range of 25M - 50M USD.

What was the EBITDA of SEV Laser during the acquisition?

SEV Laser's EBITDA is estimated to be in the range of 5M - 25M USD.

How is the data for the SEV Laser acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the SEV Laser deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.llcp.com/levine-leichtman-capital-partners-invests-in-sev-in-partnership-with-founder-and-management/

← DATABASE

Home Database Healthcare & PharmaSEV Laser

06/2023

Levine Leichtman Capital Partners invests in SEV Laser

UNITED STATES Health Providers / Outpatient Care / Aesthetic & Cosmetic Clinics EV 300M - 700M USD

Context

Structured as a structured private equity partnership, this investment by Levine Leichtman Capital Partners secures a platform investment in SEV alongside founder and Chief Executive Officer Sevana Petrosian. Announced in Los Angeles on June 21, 2023, the transaction establishes SEV as the tenth platform investment completed through the investment vehicle Levine Leichtman Capital Partners VI, L.P. Corporate governance under the recapitalized structure maintains operational leadership continuity with Sevana Petrosian and the existing executive and clinical management teams directing daily branch operations. The transaction establishes an institutional foundation to finance SEV's territorial multi-unit expansion through greenfield office openings, same-store sales acceleration, and the rollout of new aesthetic service lines across target regional markets. The partnership aligns with Levine Leichtman Capital Partners' investment mandate targeting multi-unit consumer healthcare concepts and service models. To execute the transaction, Levine Leichtman Capital Partners mandated Kirkland & Ellis LLP and Polsinelli LLP to serve as legal counsel. Sell-side advisory execution was coordinated exclusively by investment bank North Point, which acted as the exclusive financial advisor to SEV, while legal representation for SEV was managed by Buchalter, a Professional Corporation.

SEV Laser, which reported an EBITDA margin of in 2023, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.5x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 2010 in Burbank, California, by Sevana Petrosian, SEV functions as a manager and operator of medical spas specializing in aesthetic clinical treatments. The company's service portfolio centers on delivering laser hair removal, cosmetic injectables, body contouring, and advanced medical aesthetic procedures directly to consumers at an accessible price point. Operational oversight is coordinated under the ongoing leadership of founder and Chief Executive Officer Sevana Petrosian alongside dedicated in-house clinical teams. From an infrastructure standpoint, the aesthetic healthcare platform operates and manages a network of 27 clinical offices distributed across seven states. The operating format relies on standardized medical protocol execution and specialized aesthetic equipment deployed within retail-oriented clinical settings to address client demands for non-invasive cosmetic dermatology treatments.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2023

2022

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
08/2023	BAIN CAPITAL	ESTIA HEALTH	AUSTRALIA	Nursing Homes
07/2023	MEDIAN KLINIKEN	HESTIA ALLIANCE	SPAIN	Clinics / Hospitals
06/2023	PARQUEST CAPITAL	IMANEO	FRANCE	Radiology
06/2023	ARDIAN	MON VETO	FRANCE	Vet Clinics
11/2022	RADNET	HEART & LUNG IMAGING	UNITED KINGDOM	Radiology
10/2022	CBPE CAPITAL	VEINCENTRE	UNITED KINGDOM	Aesthetic & Cosmetic Clinics
09/2022	EURAZEO	IMAPOLE	FRANCE	Radiology
09/2022	ORADIANSE	REVEL	FRANCE	Radiology
08/2022	FREEMAN SPOGLI	EVERVET PARTNERS	UNITED STATES	Vet Clinics
07/2022	ANDERA PARTNERS	GROUPE RESONANCE IMAGERIE	FRANCE	Radiology

REFERENCES

Valuation range: EV 300M - 700M USD

Revenue range: 25M - 50M USD

EBITDA range: 5M - 25M USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SEV Laser by Levine Leichtman Capital Partners are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: sev laser

Acquirer: levine leichtman capital partners